Stock listing

KOD Stock Price, News, Filings & Events — Kodiak Sciences Inc

Selected listing: KOD · BOATS · USD · US

This page tracks Kodiak Sciences Inc's KOD:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following KOD:BOATS. KOD:BOATS is the stock-level entry point for investors researching Kodiak Sciences Inc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Kodiak Sciences Inc, traded under the ticker KOD, is a public company based in the United States with a market capitalization of approximately $2.67 billion. The company focuses on developing innovative therapies for eye diseases. Kodiak is committed to advancing its research and product pipeline to address unmet medical needs in ophthalmology.

KOD:BOATSUSDUSUpdated August 31, 2026
Kodiak Sciences Inc logo
Ticker
KOD:BOATS
Asset type
Stock
Market cap
$2.37B
Sector
Health Technology
Industry
Biotechnology
Exchange
BOATS
Currency
USD

Kodiak Sciences Inc KOD:BOATS stock context

This page tracks Kodiak Sciences Inc's KOD:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following KOD:BOATS. KOD:BOATS is the stock-level entry point for investors researching Kodiak Sciences Inc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Kodiak Sciences Inc, traded under the ticker KOD, is a public company based in the United States with a market capitalization of approximately $2.67 billion. The company focuses on developing innovative therapies for eye diseases. Kodiak is committed to advancing its research and product pipeline to address unmet medical needs in ophthalmology.

Latest news from Kodiak Sciences Inc

All Kodiak Sciences Inc news →

Research Kodiak Sciences Inc

Alternate listings